Abstract
We screened individuals from 443 familial breast cancer pedigrees and 521 controls for ATM sequence variants and identified 12 mutations in affected individuals and two in controls (P = 0.0047). The results demonstrate that ATM mutations that cause ataxia-telangiectasia in biallelic carriers are breast cancer susceptibility alleles in monoallelic carriers, with an estimated relative risk of 2.37 (95% confidence interval (c.i.) = 1.51–3.78, P = 0.0003). There was no evidence that other classes of ATM variant confer a risk of breast cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Shiloh, Y. Nat. Rev. Cancer 3, 155–168 (2003).
Swift, M. et al. N. Engl. J. Med. 316, 1289–1294 (1987).
Thompson, D. et al. J. Natl. Cancer Inst. 97, 813–822 (2005).
Fitzgerald, M.G. et al. Nat. Genet. 15, 307–310 (1997).
Teraoka, S.N. et al. Cancer 92, 479–487 (2001).
Sommer, S.S. et al. Cancer Genet. Cytogenet. 145, 115–120 (2003).
Gatti, R.A. et al. Mol. Genet. Metab. 68, 419–423 (1999).
Chenevix-Trench, G. et al. J. Natl. Cancer Inst. 94, 205–215 (2002).
Olsen, R.H. et al. Br. J. Cancer 93, 260–265 (2005).
Meijers-Heijboer, H. et al. Nat. Genet. 31, 55–59 (2002).
CHEK2 breast cancer case-control consortium. Am. J. Hum. Genet. 74, 1175–1182 (2004).
Antoniou, A.C. et al. Genet. Epidemiol. 25, 190–202 (2003).
Becker-Catania, S.G. et al. Mol. Genet. Metab. 70, 122–133 (2000).
Acknowledgements
We thank the participating families who were recruited to the study by the Familial Breast Cancer Collaboration (UK), which includes the following contributors: A. Ardern-Jones, J. Berg, A. Brady, N. Bradshaw, C. Brewer, G. Brice, B. Bullman, J. Campbell, B. Castle, R. Cetnarsryj, C. Chapman, C. Chu, N. Coates, T. Cole, R. Davidson, A. Donaldson, H. Dorkins, F. Douglas, D. Eccles, R. Eeles, F. Elmslie, D.G. Evans, S. Goff, S. Goodman, D. Goudie, J. Gray, L. Greenhalgh, H. Gregory, N. Haites, S.V. Hodgson, T. Homfray, R.S. Houlston, L. Izatt, L. Jeffers, V. Johnson-Roffey, F. Kavalier, C. Kirk, F. Lalloo, I. Locke, M. Longmuir, J. Mackay, A. Magee, S. Mansour, Z. Miedzybrodzka, J. Miller, P. Morrison, V. Murday, J. Paterson, M. Porteous, N. Rahman, M. Rogers, S. Rowe, S. Shanley, A. Saggar, G. Scott, L. Side, L. Snadden, M. Steel, M. Thomas, S. Thomas. We thank A. Hall and E. Mackie for coordination of sample collection. We acknowledge use of DNA from the British 1958 Birth Cohort collection, funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02. M. Ahmed and B. North are supported by the US Army Medical Research and Material Command grant #W81XWH-05-1-0204. This research was supported by the Institute of Cancer Research and by grants from the Breast Cancer Campaign and Cancer Research UK.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Table 1
Primers and PCR conditions for ATM coding exons. (PDF 68 kb)
Supplementary Table 2
Nonsynonymous ATM missense variants in breast cancer cases and controls. (PDF 58 kb)
Rights and permissions
About this article
Cite this article
Renwick, A., Thompson, D., Seal, S. et al. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet 38, 873–875 (2006). https://doi.org/10.1038/ng1837
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng1837
This article is cited by
-
The Impact of microRNA SNPs on Breast Cancer: Potential Biomarkers for Disease Detection
Molecular Biotechnology (2024)
-
Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan
Journal of Biomedical Science (2024)
-
Genetic mutations in HER2-positive breast cancer: possible association with response to trastuzumab therapy
Human Genomics (2023)
-
Germline variants of uncertain significance, their frequency, and clinico-pathological features in a cohort of Sri Lankan patients with hereditary breast cancer
BMC Research Notes (2023)
-
Identification and characterization of ATM founder mutation in BRCA-negative breast cancer patients of Arab ethnicity
Scientific Reports (2023)